Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders-Reference-Cited by-同舟云学术

Pioglitazone transiently stimulates paraoxonase-2 expression in male nonhuman primate brain: Implications for sex-specific therapeutics in neurodegenerative disorders

Published:2022-01 Issue: Volume:152 Page:105222
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Blackburn Jennifer K.,Jamwal Sumit,Wang Weiwei,Elsworth John D.

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference15 articles.

1. Role of the peroxisome proliferator-activated receptors (PPAR)-alpha, beta/delta and gamma triad in regulation of reactive oxygen species signaling in brain;Aleshin;Biol. Chem.,2013

2. Pioglitazone activates paraoxonase-2 in the brain: a novel neuroprotective mechanism;Blackburn;Exp. Neurol.,2020

3. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis;Devarajan;Antioxidants Redox Signal.,2011

4. Developmental expression of paraoxonase 2;Garrick;Chem. Biol. Interact.,2016

5. Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?;Giordano;Toxicol. Appl. Pharmacol.,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease;Parkinson's Disease;2024-01

2. Age-associated sex difference in the expression of mitochondria-based redox sensitive proteins and effect of pioglitazone in nonhuman primate brain;Biology of Sex Differences;2023-09-28

3. Pioglitazone enhances brain mitochondrial biogenesis and phase II detoxification capacity in neonatal rats with 6-OHDA-induced unilateral striatal lesions;Frontiers in Neuroscience;2023-07-28

4. PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?;International Journal of Molecular Sciences;2023-02-07

5. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments;Neuroscience & Biobehavioral Reviews;2023-01